The high mortality and morbidity that follow insertion of the Alvarez valve in the mitral position, and particularly the thrombo-embolic complications, stopped us from using it clinically in the Leeds General Infirmary.
Since the introduction of the Alvarez mitral valve prosthesis in 1964 it has been used clinically in Leeds General Infirmary because it was thought that it would produce better haemodynamic results than the other prosthetic valves.
The aim of this study is to present the longterm results in patients who had this prosthesis inserted in the mitral valve position, and to show the high incidence of thrombo-embolic manifestations.
CLINICAL MATERIAL
Since 25 August 1964 the Alvarez prosthetic valve has been inserted in the mitral position in 29 patients. This group of totally unselected patients had a mixed mitral valve lesion. They were 17 women and 12 men aged between 11 and 52 years, average age 36 years. Some of these patients had associated aortic or tricuspid valvular disease (Table I) . Two had aortic incompetence, which was thought to be mild when Associated aortic stenosis was found in only one patient; it was thought to be mild and was not treated, but the patient died one month after operation and necropsy revealed moderately severe aortic stenosis. Seven patients had had previous operations on the mitral valve (Table II) . Calcification was present in 19 of the 29 patients. All the 29 patients had severe disease of the chordae tendineae, so that none of the valves was suiitable for repair.
The operative technique was the same in all patients, using the Melrose machine for extracorporeal circulation, combined with mild hypothermia to 330 or 34°C. The heart was fibrillated electrically on full perfusion. Tracheostomy at the end of the operation was performed only when necessary.
All the patients were anticoagulated on the fifth post-operative day.
RESULTS
Out of the 29 patients mentioned above, 14 are still alive. The time and cause of death of the 15 deceased patients is given in Tables III, IV , V, and VI respectively.
Considering Table VI , in patient 1 there is conclusive evidence that clotting occurred on the valve, necessitating re-operation to remove that (Table VI) developed torrential haemorrhage from a duodenal ulcer and anticoagulants had to be stopped. Immediately afterwards he developed a cerebral embolus and died in hospital.
Patient 4 also died one year after operation from a cerebral embolus which produced a right hemiplegia.
Both patients 5 and 6 (Table VI) died suddenly at home, presumably due to cerebral emboli, because their hearts were good and indeed they were more or less symptomless before they died.
All patients were found to be grade IIB preoperatively when their exercise tolerance was assessed. Their exercise tolerance grading after operation is shown in Table VII . The rate is very high for the Alvarez prosthesis and we believe that it is due to clot forming on the hinge joint mechanism (Figure) . We therefore ceased to use this prosthesis after February 1967 because we were unable to prevent systemic emboli with full anticoagulant control.
FIGURE Photograph and artist's sketch of clot forming over the Alvarez prosthetic valve. Starr, Herr, and Wood (1967) 
